From July 1, 2022 to December 31, 2022, the company has repurchased 12,078,000 shares, representing 2.94% for HKD 18.44 million. With this, the company has completed the repurchase of 13,412,000 shares, representing 3.28% for HKD 20.54 million under the buyback announced on June 24, 2022.
Lansen Pharmaceutical Holdings Limited
Equities
503
KYG5380M1033
Pharmaceuticals
1st Jan change | Capi. | |
---|---|---|
+60.25% | 841B | |
+38.56% | 625B | |
-4.49% | 360B | |
+18.30% | 327B | |
+9.64% | 300B | |
+14.15% | 242B | |
+3.11% | 228B | |
+16.98% | 227B | |
+12.87% | 174B |